The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,779.00
Bid: 1,778.50
Ask: 1,779.00
Change: -9.50 (-0.53%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,777.00
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European gas inventories back to 10-year average

Wed, 17th Aug 2022 12:19

EUROPEAN GAS INVENTORIES BACK TO 10-YEAR AVERAGE (1117 GMT)

As well as watching trading screens, market players are keeping one eye on European gas supplies as a key metric when weighing up the economic outlook.

According to UBS analysts, European gas storage usage reached its 10-year average at the beginning of August.

As of August 13, storage was 74% full - above last year's level of 61%. At this rate, by the end of October storage levels could be near to 90%, the analysts said in a note.

We can thank liquid natural gas imports for that.

"Imports (of LNG) were up 110% y/y in July and are up 61% y/y YTD which helps to offset low volumes from Russia," they said in a note.

On the other hand, Russian exports have continued to decline.

"In 1H Aug Gazprom exports to Europe stood at ~2.6bcm, down 64% y/y, close to the July daily average."

The analysts said they expect LNG imports in Europe to remain close to first half levels in the second half, but that "risks are to the downside", with potentially more competition from Asian buyers and risk of supply disruptions.

"And these come at a high price, TTF (front-month) approaching €250/MWh today."

STOXX 600: NOT MUCH TO EXPECT FROM EARNINGS NOW (0926 GMT)

The better-than-expected Q2 earnings season, along with a weaker euro, was an essential driver of the summer rally which has lifted the pan-European STOXX 600 over 10% since the June lows.

But as you see can below from the latest Refinitiv I/B/E/S estimates, profit growth is expected to reverse into an earnings recession in 2023:

Moving forward, European stocks, still down over 9% year-to-date, will therefore not likely be able to count on earnings to rebound further this year.

"Q2 earnings have not been the disaster some had predicted, but mixed guidance, high inventories and rising margin pressures offer little comfort", Barclays strategists argued in a note.

So with little to expect from earnings growth, multiples need to expand for the rally to keep on going.

"As slowing growth caps the upside to FY estimates, at best, the bull case for equities relies on renewed P/E expansion", they wrote, calling such a re-rating "elusive".

Then again, as they show in this chart, the low level of European price-to-earnings ratios seems to suggest that there is potentially some upside:

(Julien Ponthus)

STOXX SET FOR SIXTH CONSECUTIVE DAY OF GAINS (0753 GMT)

European shares are into their sixth consecutive day of gains, with the STOXX 600 opening 0.3% higher as markets continue to brush off fears of an energy crisis and recession on the continent.

The financial services sector is leading gains with a 0.88% rise, while healthcare and basic resources are ringing in at the bottom, down 0.22% and 0.35% respectively.

Shares in Uniper are falling 8.2% and are at the bottom of the STOXX 600, unsurprising given the company just reported a hefty 12 billion euro loss in the first half .

Shares in GSK are down 2.1% but stayed above recent lows after the plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial agreed to drop his case .

At the top of the index is Swiss laboratory instruments maker Tecan Group, surging 12% after a H1 beat and raising its FY sales outlook.

MORE DOOM AND GLOOM LOOMS FOR EUROPE (0640 GMT)

Europeans will be hoping Wednesday’s economic data will provide some respite after a string of negative headlines, but past form suggests they’d be foolish to bet too much on it.

They might even be better off taking a punt on depressing figures, as at least their winnings might provide some small cheer if the bad news arrives.

British consumer price inflation jumped to 10.1% in July, its highest since February 1982, up from an annual rate of 9.4% in June, intensifying the squeeze on households, official figures showed on Wednesday

That’s not good news for British workers who saw earnings for the second quarter adjusted for inflation fall by 4.1%, the biggest drop since records began in 2001, according to data released on Tuesday.

The final reading for Euro zone Q2 GDP is also due on Wednesday, and while preliminary data showed faster than expected growth, even then economists said it might be the economy's last hurrah.

If data from down under offers any clues, they aren’t great.

Earlier on Wednesday New Zealand’s Central Bank signalled a more hawkish tightening path over coming months to restrain stubbornly high inflation, even as it delivered its seventh straight interest rate hike, and Australian wage growth missed forecasts and lagged badly behind inflation.

The kiwi dollar initially climbed on the news before giving up its gains, though the Aussie held onto its losses.

Asian shares eked out small gains in morning trading, following overnight gains on Wall Street, where economic data is less depressing.

Japan was in the lead with the Nikkei up 1%, while MSCI’s broadest index of shares outside Japan rose just 0.2%.

Key developments that could influence markets on Wednesday:

UK Jul CPI, Jul PPI

Euro zone Q2 flash employment, Q2 GDP

US Jul retail sales

US 20-year Treasury auction

Fed Reserve releases minutes from July policy meeting at 1800 GMT

New Zealand's central bank meeting and press conference.

European earnings: Swiss Life, Carlsberg, Uniper

US earnings: Lowe’s, Target, Cisco

(Alun John)

WHAT ECONOMIC GLOOM?: (0629 GMT)

European shares look set for their sixth consecutive day of rises, with futures contracts signalling increases of 0.3% as they track U.S. shares which posted gains on Tuesday after some strong showings from major retailers.

U.S. retail sales data will give a further insight today but in the meantime there are some not so pretty earnings coming out of Europe to contend with.

Danish brewer Carlsberg reported Q2 sales below expectations, while Germany's Uniper, which secured a 15 billion euro bailout last month, reported a net loss of more than 12 billion euros ($12.2 billion) for the first half.

Better news is coming from insurer Swiss Life which has increased its half year net profit by 4%.

On the data front, UK CPI was seen rising to the highest level since 1982, up to 10.1% in July from 9.4% in June.

(Lucy Raitano)

More News
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.